A popular group of weight loss medications is glucagon-like peptide-1 receptor agonists (GLP-1RAs) , which include the likes of Ozempic and Wegovy — medications that are used to treat type 2 diabetes and obesity. A study recently published in Diabetes, Obesity and Metabolism explored weight fluctuations among participants after taking GLP-1RAs. The results suggest that factors like taking GLP-1RAs longer, having greater accumulated exposure to GLP-1RAs, using semaglutide, and not having